• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢途径中的遗传多态性与非霍奇金淋巴瘤的生存。

Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.

机构信息

Yale University School of Public Health, 60 College Street, New Haven, CT 06520-8034, USA.

出版信息

Am J Hematol. 2010 Jan;85(1):51-6. doi: 10.1002/ajh.21580.

DOI:10.1002/ajh.21580
PMID:20029944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2964927/
Abstract

Metabolic pathway enzymes, such as Cytochrome P450 (CYP), glutathione S-transferase (GST), and N-acetyltransferases (NAT) are involved in activation and detoxification of environmental carcinogens as well as drug metabolism. We hypothesized that the genetic variations in such metabolic pathways may affect NHL prognosis and survival. Follow-up information of 496 female NHL incident cases diagnosed during 1996-2000 in Connecticut were abstracted from the Connecticut Tumor Registry in 2008; survival analyses were conducted by comparing the Kaplan-Meier curves, and hazard ratios (HR) were computed from the Cox Proportional Hazard models adjusting for demographic and tumor characteristics which were suggested by previous studies to be determinants of NHL survival. We identified six SNPs from four metabolism genes (CYP2E1, GSTP1, GSTT1, and NAT1) that were associated with NHL survival. Specifically, polymorphisms in GSTT1 were associated with follicular lymphoma survival; and polymorphisms in CYP2E1, GSTP1, and NAT1 were associated with survival of chronic lymphocytic leukemia/small lymphocytic lymphoma. Our study suggests that genetic polymorphisms in metabolic pathways may help improve the prediction of NHL survival and prognosis.

摘要

代谢途径酶,如细胞色素 P450(CYP)、谷胱甘肽 S-转移酶(GST)和 N-乙酰基转移酶(NAT),参与环境致癌物的激活和解毒以及药物代谢。我们假设这些代谢途径中的遗传变异可能会影响 NHL 的预后和生存。2008 年,我们从康涅狄格州肿瘤登记处提取了 1996-2000 年期间在康涅狄格州诊断出的 496 名女性 NHL 发病病例的随访信息;通过比较 Kaplan-Meier 曲线进行生存分析,并根据先前研究建议的人口统计学和肿瘤特征对 Cox 比例风险模型进行调整,计算危险比(HR),这些特征被认为是 NHL 生存的决定因素。我们从四个代谢基因(CYP2E1、GSTP1、GSTT1 和 NAT1)中确定了六个与 NHL 生存相关的 SNP。具体来说,GSTT1 中的多态性与滤泡性淋巴瘤的生存有关;而 CYP2E1、GSTP1 和 NAT1 中的多态性与慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的生存有关。我们的研究表明,代谢途径中的遗传多态性可能有助于改善 NHL 生存和预后的预测。

相似文献

1
Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.代谢途径中的遗传多态性与非霍奇金淋巴瘤的生存。
Am J Hematol. 2010 Jan;85(1):51-6. doi: 10.1002/ajh.21580.
2
Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.免疫功能基因多态性与非霍奇金淋巴瘤生存。
J Cancer Surviv. 2012 Mar;6(1):102-14. doi: 10.1007/s11764-010-0164-4. Epub 2011 Nov 24.
3
N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.N-乙酰转移酶基因多态性与淋巴瘤亚型的风险相关。
Hematol Oncol. 2016 Jun;34(2):79-83. doi: 10.1002/hon.2193. Epub 2015 Feb 17.
4
Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.外源性代谢途径基因的遗传变异、个人染发剂使用情况与非霍奇金淋巴瘤风险
Am J Epidemiol. 2009 Nov 15;170(10):1222-30. doi: 10.1093/aje/kwp263. Epub 2009 Oct 12.
5
Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.GST 基因遗传多态性与接受化疗的结直肠癌患者生存的关系。
Pharmacogenomics. 2010 Jan;11(1):33-41. doi: 10.2217/pgs.09.132.
6
Impact of CYP2E1, GSTA1 and GSTP1 gene variants on serum alpha glutathione S-transferase level in patients undergoing anaesthesia.CYP2E1、GSTA1和GSTP1基因变异对接受麻醉患者血清α-谷胱甘肽S-转移酶水平的影响。
BMC Med Genet. 2016 May 14;17(1):40. doi: 10.1186/s12881-016-0302-6.
7
Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.CYP2E1、GST 和 NAT2 酶的遗传多态性与黎巴嫩女性样本中的乳腺癌风险无关。
Mutat Res. 2013 Jul-Aug;747-748:40-7. doi: 10.1016/j.mrfmmm.2013.04.004. Epub 2013 Apr 27.
8
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma.谷胱甘肽-S-转移酶基因型影响滤泡性非霍奇金淋巴瘤的预后。
Leuk Lymphoma. 2007 Mar;48(3):564-9. doi: 10.1080/10428190601158647.
9
Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.NAT2、GSTM1、GSTT1、CYP2E1 基因与环境因素的遗传相互作用与抗结核药物不良反应有关。
Mol Diagn Ther. 2012 Aug 1;16(4):241-50. doi: 10.1007/BF03262213.
10
Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review.GSTM1、GSTT1 和 GSTP1 Ile105Val 多态性在霍奇金淋巴瘤和非霍奇金淋巴瘤风险中的作用:人类基因组流行病学(HuGE)综述。
Leuk Lymphoma. 2013 Jan;54(1):14-20. doi: 10.3109/10428194.2012.706284. Epub 2012 Aug 13.

引用本文的文献

1
An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment.CYP450 在调节急性髓系白血病微环境中外源物质代谢中的作用的最新概述。
Int J Mol Sci. 2023 Mar 23;24(7):6031. doi: 10.3390/ijms24076031.
2
Clinicopathological Characteristics and Molecular Phenotypes of Primary Hepatic Lymphoma.原发性肝淋巴瘤的临床病理特征及分子表型
Front Oncol. 2022 Jun 27;12:906245. doi: 10.3389/fonc.2022.906245. eCollection 2022.
3
Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.

本文引用的文献

1
Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.外源性代谢途径基因的遗传变异、个人染发剂使用情况与非霍奇金淋巴瘤风险
Am J Epidemiol. 2009 Nov 15;170(10):1222-30. doi: 10.1093/aje/kwp263. Epub 2009 Oct 12.
2
E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2.大肠杆菌硝基还原酶/CB1954基因导向的酶前药疗法:芳胺N-乙酰基转移酶2的作用
Cancer Gene Ther. 2008 Nov;15(11):758-64. doi: 10.1038/cgt.2008.47. Epub 2008 Jul 4.
3
Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
肝细胞癌中糖酵解/胆固醇生成基因表达的改变。
Aging (Albany NY). 2020 Jun 1;12(11):10300-10316. doi: 10.18632/aging.103254.
4
Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells.甲状腺激素通过淋巴瘤T细胞中参与化疗代谢的酶诱导阿霉素化疗敏感性。
Oncotarget. 2019 Apr 30;10(32):3051-3065. doi: 10.18632/oncotarget.26890.
5
Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.精准药物设计及疾病易感性背后基因特征识别的综合策略——一种药物基因组学方法
Funct Integr Genomics. 2017 Jul;17(4):375-385. doi: 10.1007/s10142-017-0559-7. Epub 2017 May 3.
6
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia.急性淋巴细胞白血病复发的特定血统风险遗传学
Leukemia. 2017 Jun;31(6):1325-1332. doi: 10.1038/leu.2017.24. Epub 2017 Jan 18.
7
Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability.临床应用中启动子区域单核苷酸多态性选择的方法学。其适用性示例。
Int J Mol Epidemiol Genet. 2016 Sep 30;7(3):126-136. eCollection 2016.
8
Effects of polymorphisms in alcohol metabolism and oxidative stress genes on survival from head and neck cancer.酒精代谢和氧化应激基因多态性对头颈部癌症患者生存的影响。
Cancer Epidemiol. 2013 Aug;37(4):479-91. doi: 10.1016/j.canep.2013.03.010. Epub 2013 Apr 28.
9
Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.NAT2 和 GSTP1 基因多态性与口腔和口咽癌患者的生存相关。
Cancer Epidemiol. 2013 Aug;37(4):505-11. doi: 10.1016/j.canep.2013.02.009. Epub 2013 Mar 21.
10
Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.CYP2E1 mRNA 和蛋白的过度表达:伴 inv(16)(p13.1q22); CBFβ-MYH11 的初发急性髓系白血病中外源物诱导损伤的意义。
Int J Environ Res Public Health. 2012 Aug;9(8):2788-800. doi: 10.3390/ijerph9082788. Epub 2012 Aug 3.
外源性物质代谢酶基因(CYP2E1、CYP2C19、CYP2D6、mEH和NAT2)多态性在乳腺癌中的意义
BMC Cancer. 2008 Apr 18;8:109. doi: 10.1186/1471-2407-8-109.
4
Lymphoma survival patterns by WHO subtype in the United States, 1973-2003.1973 - 2003年美国按世界卫生组织亚型分类的淋巴瘤生存模式
Cancer Causes Control. 2008 Oct;19(8):841-58. doi: 10.1007/s10552-008-9147-4. Epub 2008 Mar 26.
5
Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.药物代谢酶CYP1A1、GSTT和GSTP的多态性有助于沙特阿拉伯人群中弥漫性大B细胞淋巴瘤风险的发展。
Leuk Lymphoma. 2008 Jan;49(1):122-9. doi: 10.1080/10428190701704605.
6
Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.成年俄罗斯患者中异生物质代谢基因多态性与慢性淋巴细胞白血病和非霍奇金淋巴瘤风险的关系
Am J Hematol. 2008 Apr;83(4):279-87. doi: 10.1002/ajh.21113.
7
Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.编码药物代谢酶的基因多态性及其对神经母细胞瘤患儿预后的影响。
Pharmacogenet Genomics. 2007 Sep;17(9):709-17. doi: 10.1097/FPC.0b013e3280e1cc92.
8
NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations.阿曼胃癌患者的NAT2基因多态性——风险易感性及临床病理关联
World J Gastroenterol. 2007 May 21;13(19):2697-702. doi: 10.3748/wjg.v13.i19.2697.
9
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma.谷胱甘肽-S-转移酶基因型影响滤泡性非霍奇金淋巴瘤的预后。
Leuk Lymphoma. 2007 Mar;48(3):564-9. doi: 10.1080/10428190601158647.
10
Endogenous glutathione adducts.内源性谷胱甘肽加合物
Curr Drug Metab. 2006 Dec;7(8):853-72. doi: 10.2174/138920006779010601.